$2.76
Anixa Biosciences is a biotechnology business based in the US. Anixa Biosciences shares (ANIX) are listed on the NASDAQ and all prices are listed in US Dollars. Anixa Biosciences employs 4 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Anixa Biosciences stock
How to buy Anixa Biosciences stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ANIX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Anixa Biosciences stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Anixa Biosciences stock price (NASDAQ: ANIX)
Use our graph to track the performance of ANIX stocks over time.Anixa Biosciences shares at a glance
Latest market close | $2.89 |
---|---|
52-week range | $2.15 - $5.13 |
50-day moving average | $2.62 |
200-day moving average | $3.34 |
Wall St. target price | $7.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.37 |
Is it a good time to buy Anixa Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Anixa Biosciences price performance over time
Historical closes compared with the close of $2.89 from 2024-07-23
1 week (2024-07-17) | -8.25% |
---|---|
1 month (2024-06-24) | 15.60% |
3 months (2024-04-24) | -9.12% |
6 months (2024-01-24) | -39.54% |
1 year (2023-07-24) | -22.93% |
---|---|
2 years (2022-07-20) | N/A |
3 years (2021-07-23) | 4.25 |
5 years (2019-07-24) | 4.61 |
Anixa Biosciences financials
Gross profit TTM | $127,498 |
---|---|
Return on assets TTM | -31.21% |
Return on equity TTM | -48.41% |
Profit margin | 0% |
Book value | $0.74 |
Market Capitalization | $94.1 million |
TTM: trailing 12 months
Anixa Biosciences share dividends
We're not expecting Anixa Biosciences to pay a dividend over the next 12 months.
Have Anixa Biosciences's shares ever split?
Anixa Biosciences's shares were split on a 1:25 basis on 25 June 2015. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Anixa Biosciences shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Anixa Biosciences shares which in turn could have impacted Anixa Biosciences's share price.
Anixa Biosciences share price volatility
Over the last 12 months, Anixa Biosciences's shares have ranged in value from as little as $2.145 up to $5.13. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Anixa Biosciences's is 0.894. This would suggest that Anixa Biosciences's shares are less volatile than average (for this exchange).
Anixa Biosciences overview
Anixa Biosciences, Inc. , a clinical-stage biotechnology company, focuses on the treatment and prevention of cancer. Its therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR- T, known as chimeric endocrine receptor T-cell (CER-T) technology. The company's vaccine portfolio includes a novel vaccine being developed in collaboration with Cleveland Clinic to prevent breast cancer " primarily triple negative breast cancer (TNBC), the lethal form of the disease, as well as a vaccine to prevent ovarian cancer. Its vaccine technologies focus on immunizing against retired proteins that found to be expressed in certain forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018.
Frequently asked questions
nullWhat percentage of Anixa Biosciences is owned by insiders or institutions?
Currently 5.058% of Anixa Biosciences shares are held by insiders and 16.491% by institutions. How many people work for Anixa Biosciences?
Latest data suggests 4 work at Anixa Biosciences. When does the fiscal year end for Anixa Biosciences?
Anixa Biosciences's fiscal year ends in October. Where is Anixa Biosciences based?
Anixa Biosciences's address is: 3150 Almaden Expressway, San Jose, CA, United States, 95118 What is Anixa Biosciences's ISIN number?
Anixa Biosciences's international securities identification number is: US03528H1095 What is Anixa Biosciences's CUSIP number?
Anixa Biosciences's Committee on Uniform Securities Identification Procedures number is: 45069V104
More guides on Finder
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Frec review 2024: Low-cost direct indexing and individual stock trading
A deep dive into the highlights and limitations of Frec.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question